ANI Pharmaceuticals Inc (ANIP)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 428,530 430,798 455,760 451,963 432,749 454,711 434,472 339,482 338,540 336,675 336,958 346,094 358,740 191,403 191,917 203,712 195,700 195,100 191,344 201,171
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $428,530K)
= 0.00

The debt-to-capital ratio of ANI Pharmaceuticals Inc has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt to finance its operations or investments. A debt-to-capital ratio of 0.00 implies that the company's capital structure is mainly composed of equity, which can be seen as a positive sign as it signifies lower financial risk and less dependence on external borrowing. ANI Pharmaceuticals Inc's consistent 0.00 debt-to-capital ratio suggests a stable and conservative approach to its financial management, where the company has effectively managed its capital structure without taking on significant debt obligations.